Cycurion is trading at $0.57 (-5.91%) on August 10, 2026, amid continued concern about its Nasdaq listing status.
- The company’s Nasdaq hearing is scheduled for August 20, 2026; its stock remains listed pending the Panel’s decision.
- Recent warrant-inducement financing and dilution concerns may be adding pressure after several consecutive declines.
- Broader markets are only modestly lower, making company-specific listing risk the clearer explanation.